COVID-19 Therapeutics Whirlwind webinar

C

CRE Reduce

Guest

[TR]
[TD]
6.00 pm AEST Welcome and introduction
Professor Jason Roberts, The University of Queensland CRE REDUCE

6.05 pm | 7.05 pm AEDT Lessons learned for running clinical trials in a pandemic
A/Prof Steven Tong, The Doherty Institute, Australia

[/TD]
[/TR]
[TR]
[TD]
6.25 pm AEST Latest data for steroids in COVID-19
Prof Bala Venkatesh, The George Institute for Global Health | Wesley Medical Research, Australia

[/TD]
[/TR]
[TR]
[TD]
6.45 pm | 2.45 am CST Antiviral drugs for SARS-CoV-2
Prof Andre Kalil, University of Nebraska Medical Center, United States of America

[/TD]
[/TR]
[TR]
[TD]
7.05pm | 8.05pm AEDT Antibody therapy for COVID-19
A/Prof Zoe McQuilten, Monash University, Australia

[/TD]
[/TR]
[TR]
[TD]
7.25 pm IL-6 pathway inhibitors for COVID-19
A/Prof Bridget Barber, QIMR Berghofer Medical Research Institute, Australia

[/TD]
[/TR]
[TR]
[TD]
7.45 pm | 3.15 pm IST What approaches for thromboprophylaxis should be therapy for COVID-19?
Dr M Joseph John, Christian Medical College Ludhiana, Punjab

[/TD]
[/TR]
[TR]
[TD]
8.05 pm | 11.05 am CET How does critical illness change treatment approaches to COVID-19?
Prof Jan De Waele, Ghent University Hospital, Belgium

[/TD]
[/TR]
[TR]
[TD]
8.25 pm | 11.25 am CET A national healthcare response to intensive care bed requirements during the COVID-19 outbreak in France
Prof Jean-Yves Lefrant, Centre Hospitalier Universitaire de Nîmes, France


8.45pm AEST | 9.45pm AEDT | 11.45am CET | 4.45am CST | 4.15 PM IST Close
[/TD]
[/TR]

Lihat lebih lengkap di https://cre-reduce.centre.uq.edu.au/events
 
Top